-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Myeloproliferative/Myelodysplastic Overlap Syndromes

Program: Education Program
Session: Myeloproliferative Neoplasms: A Clinical Update
Saturday, December 5, 2015, 7:30 AM-9:00 AM
W224, Level 2 (Orange County Convention Center)
Saturday, December 5, 2015, 4:00 PM-5:30 PM
W224, Level 2 (Orange County Convention Center)

Eric Padron, M.D.

Division of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL

Disclosures: Off Label Use: Ruxolitinib for the treatment of CMML and aCML.

See more of: Myeloproliferative Neoplasms: A Clinical Update
See more of: Education Program
<< Previous Presentation | Next Presentation